ALGERIA PHARMACEUTICAL MARKET

KEY FINDINGS

1. Algeria pharmaceutical market is estimated at ~$4.5-$4.7B in 2023 and is growing at higher double digits
2. Approx. 55% of the market comprises locally manufactured drugs
3. Post COVID, there has been a surge of favorable policies by the local govt to encourage foreign pharma companies participation and increase domestic production
4. Among the notable improvements in the govt policies includes reducing the wait time to register new drugs(up to 5 months for proprietary drugs and up to 3 months for generic drugs)
5. There are more than 80 pharma companies presently active in the market and Groupe Saida is among the leading players
6. In recent years, Algeria has received sizable Foreign investment from French pharma companies. The local govt has capped the shareholding of foreign investors at 49% of any entity

INTRODUCTION

Algeria is continuing its efforts to lower the cost of importing medicines that have been used for a number of years. 

Algeria's pharmaceutical industry is in a strong position to export. It is one of Algeria's best-developed industries, and its assets enable it to rapidly transition to export, particularly to Africa.

The public authorities have set themselves the goal of achieving national drug needs and developing local production of all drugs in order to reduce dependence on foreign labs.

ALGERIA PHARMACEUTICAL MARKET SIZE AND FORECAST

The Algeria Pharmaceutical Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

ALGERIA PHARMACEUTICAL MARKET DYNAMICS

Algeria produced biosimilar medicines for the first time: derived from living things. By focusing  Frater Razes production on biosimilars and the production of products from cell culture, they have anticipated this trend in the same way that international laboratories have done through pharmaceutical innovation.

For the past two decades, this item had been imported. They have ensured Algerian patients' self-sufficiency for the nation.

The laboratory intends to expand its exports right now. However, a further step toward self-sufficiency is another priority, and the company anticipates soon being able to synthesize organic substances as a result of its research.

They will produce their own raw materials, guarantee biosynthesis, and complete the manufacturing from A to Z. The country has undergone a paradigm shift as a result of a number of reforms, with health products becoming a growth engine rather than an economic burden. 

THIS ALGERIA PHARMACEUTICAL MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Pharmaceutical are manufactured per annum in Algeria? Who are the sub-component suppliers in this regions?
2. Cost breakup of a Algeria Pharmaceutical and key vendor selection criteria
3. Where is the Pharmaceutical manufactured? What is the average margin per unit?
4. Market share of Algeria Pharmaceutical market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Algeria  Pharmaceutical in-house
6. key predictions for next 5 years in Algeria Pharmaceutical market
7. Average B-2-B Pharmaceutical market price in all segments
8. Latest trends in Pharmaceutical market, by every market segment
9. The market size (both volume and value) of the Pharmaceutical market in 2024-2030 and every year in between?
10. Production breakup of Pharmaceutical market, by suppliers and their OEM relationship